HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Type II diabetes mellitus. Rosiglitazone is effective against insulin resistance].

AuthorsH Oberpichler-Schwenk
JournalMedizinische Monatsschrift fur Pharmazeuten (Med Monatsschr Pharm) Vol. 22 Issue 9 Pg. 288-9 (Sep 1999) ISSN: 0342-9601 [Print] Germany
Vernacular TitleDiabetes mellitus Typ II. Rosiglitazon wirkt Insulinresistenz entgegen.
PMID10577070 (Publication Type: Journal Article)
Chemical References
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Rosiglitazone
Topics
  • Diabetes Mellitus, Type 2 (drug therapy, physiopathology)
  • Drug Therapy, Combination
  • Glycated Hemoglobin (analysis)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Insulin Resistance
  • Rosiglitazone
  • Thiazoles (therapeutic use)
  • Thiazolidinediones

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: